Search results for " Ly"

showing 10 items of 2487 documents

Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases

2019

Background: The indication to sentinel node biopsy (SNB) for thin melanomas (Breslow <1 mm) is still subject to controversies. The aim of this paper is to review all SNB performed for thin melanoma and to analyze factors related to lymphatic metastasis. Moreover, the diagnostic performance of the 5th, 6th, 7th and 8th AJCC classifications for cutaneous melanoma were investigated. Methods: All sentinel node biopsies performed for thin melanomas were selected from a multicentre prospectively-collected database. For each patient the following was collected: age, sex, date of treatment, site of primary melanoma, histopathologic features (Breslow, Clark, number of mitoses/mm2 , presence of ul…

Malemedicine.medical_specialtySkin NeoplasmsMultivariate analysisRisk AssessmentBreslow Thickness03 medical and health sciencesMelanoma; Sentinel node; Sentinel node biopsy; Thin melanoma0302 clinical medicineRisk FactorsBiopsyHumansMedicineProspective Studies030212 general & internal medicineSkin NeoplasmRisk factorProspective cohort studyMelanomaThin melanomaSentinel node biopsyMelanoma; Sentinel node; Sentinel node biopsy; Thin melanoma; Surgery; Oncologymedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyMelanomaRisk FactorLymphatic MetastasiGeneral MedicineSentinel nodeMiddle Agedmedicine.diseaseProspective StudieOncologySentinel nodeLymphatic Metastasis030220 oncology & carcinogenesisCutaneous melanomaSurgeryFemaleRadiologybusinessHuman
researchProduct

Sentinel lymph node biopsy in malignant melanoma of the head and neck

2018

Abstract Background The aim of this retrospective study was to investigate sentinel lymph node biopsy in patients with head and neck melanoma. Materials and methods Patients who underwent SLNB between 2010 and 2016 were comprised. Epidemiological, radiological, and surgical data were collected and compared to histological findings. Patients who underwent primary complete lymph node dissection were excluded. Results 74 patients underwent SLNB during this period. The most common tumor localizations were the cheek (20.4%) and ears (20.4%). Overall, 256 sentinel lymph nodes (SLN) were detected and removed, most frequently in Robbins-levels IIA and IIB as well as in the surrounding of the paroti…

Malemedicine.medical_specialtySkin NeoplasmsSentinel lymph nodeMetastasis030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePredictive Value of TestsBiopsyHumansParotid GlandMedicineMelanomaLymph nodeAgedNeoplasm StagingRetrospective Studiesmedicine.diagnostic_testSentinel Lymph Node Biopsybusiness.industryMelanomaEarMiddle AgedPrognosismedicine.diseaseParotid glandCheekLymphatic systemmedicine.anatomical_structureOtorhinolaryngologyHead and Neck NeoplasmsLymphatic Metastasis030220 oncology & carcinogenesisLymph Node ExcisionFemaleSurgeryLymph NodesLymphRadiologyNeoplasm Recurrence LocalOral SurgerybusinessHeadNeckJournal of Cranio-Maxillofacial Surgery
researchProduct

A Proposal for Novel Standards of Histopathology Reporting for D3 Lymphadenectomy in Right Colon Cancer: The Mesocolic Sail and Superior Right Colic …

2020

Background Strong agreement exists concerning the standards of pathologic reporting for total mesorectal excision and complete mesocolic excision. It represents a quality standard that correlates with survival. However, no agreed standards of reporting are available to define D3 lymphadenectomy for right colectomy. Objective The purpose of this study was to define anatomopathological standards of specimen quality obtained from the surgical specimen when an oncologic right hemicolectomy with D3 lymphadenectomy has been correctly performed. Design This study was conducted in 2 different phases. The first part consisted of a cadaver-based study of right colon anatomy, and the second part consi…

Malemedicine.medical_specialtySurgical specimen03 medical and health sciencesMesenteric Veins0302 clinical medicineD3 lymphadenectomyCadaverHumansMedicineD3 lymphadenectomyProspective StudiesColectomyAgedNeoplasm StagingAged 80 and overNew quality standardsbusiness.industryRight colic veinGastroenterologyOutcome measuresGeneral MedicineMiddle AgedColon cancermedicine.anatomical_structureSpecimen QualityLymphatic Metastasis030220 oncology & carcinogenesisQuality standardColonic NeoplasmsRight ColectomyLymph Node ExcisionFemaleLaparoscopy030211 gastroenterology & hepatologyHistopathologyLymph NodesAnatomic LandmarksbusinessNuclear medicineFollow-Up StudiesDiseases of the Colon & Rectum
researchProduct

Sudden infant death caused by a ruptured coronary aneurysm during acute phase of atypical Kawasaki disease

2001

This article describe's a case of atypical Kawasaki disease (AKD) with lack of typical clinical signs and rapid fatal course in a 2-month-old infant, who 1 week before hospitalization demonstrated rhinitis, coughing without fever, and later conjunctival hyperemia and allergic exanthema on chest and arms. On admittance, labwork highlighted the following: leukocytosis, thrombocytosis, elevated sedimentation rate, and positive C-reactive protein. General conditions remained mediocre for 7 days until sudden death occurred. The autopsy confirmed death caused by cardiac tamponade caused by a ruptured inflammated aneurysm of the left anterior descending coronary artery. We believe that the current…

Malemedicine.medical_specialtyThrombocytosisbusiness.industryVascular diseaseCoronary AneurysmInfantAutopsyMucocutaneous Lymph Node Syndromemedicine.diseaseSudden deathPathology and Forensic MedicineSurgeryFatal OutcomeCardiac tamponadeAcute DiseasemedicineHumansKawasaki diseaseLeukocytosismedicine.symptombusinessComplicationSudden Infant DeathHuman Pathology
researchProduct

Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hor…

2012

OBJECTIVE: An increased prevalence of hematological abnormalities is reported in acromegaly, but to date no reports about the presence of the Janus Kinase (JAK) 2 mutation in acromegalic patients have been described. DESIGN: We report the complex clinical presentation of the unique case, never described, of acromegaly due to GH-secreting pituitary adenoma associated with JAK2 V617F mutation. RESULTS: The patient shows primary thrombocythemia and myelofibrosis, due to JAK2 V617F mutation, severe visceromegaly and a peculiar clinical course of the disease characterized by discrepant values of GH and IGF-1 during somatostatin analog (SA) treatment despite a significant reduction in pituitary a…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismGrowth hormone receptorAcromegaly HGH IGF-1GastroenterologySettore MED/13 - EndocrinologiaCohort StudiesEndocrinologyPituitary adenomahemic and lymphatic diseasesInternal medicineAcromegalymedicineAnimalsHumansPituitary NeoplasmsInsulin-Like Growth Factor IRadiometryMyelofibrosisAgedJanus kinase 2biologyHuman Growth HormonePlatelet Countbusiness.industryJanus Kinase 2medicine.diseaseAcromegaly Growth hormone Insulin-like growth factor-1 Janus kinase 2 Growth hormone receptorEndocrinologyAcromegalyMutationPegvisomantbiology.proteinJanus kinasebusinessVisceromegalyFollow-Up StudiesThrombocythemia Essentialmedicine.drug
researchProduct

The impact of ovarian stimulation on the expression of candidate reprogramming genes in mouse preimplantation embryos.

2012

Ovarian stimulation with gonadotrophins is an integral part of assisted reproductive technologies in human subfertility/infertility treatment. Recent findings have associated ovarian stimulation with the increased incidence of imprinting disorders in humans as well as defects in genome-wide methylation reprogramming and, in particular, imprinting in mice. Here, we present the first study that determined the impact of ovarian stimulation on the expression of developmentally important reprogramming genes <i>(Apex1, Lig1, Lig3, Mbd2, Mbd3, Mbd4, </i>and<i> Polb)</i> in single early mouse morula embryos (16-cell stage). Using absolute quantification of mRNA by quantitati…

Malemedicine.medical_specialtyTime FactorsGonadotropins EquineDown-RegulationStimulationReproductive technologyBiologyChorionic GonadotropinMBD4AndrologyMiceOogenesisOvulation InductionInternal medicineGeneticsmedicineDNA-(Apurinic or Apyrimidinic Site) LyaseAnimalsHumansHorsesRNA MessengerMolecular BiologyGenetics (clinical)GametogenesisDNA Polymerase betaRegulation of gene expressionReverse Transcriptase Polymerase Chain ReactionEmbryogenesisGene Expression Regulation DevelopmentalEmbryoDNA-Binding ProteinsMice Inbred C57BLEndocrinologyBlastocystMicroscopy Fluorescenceembryonic structuresFemaleReprogrammingTranscription FactorsCytogenetic and genome research
researchProduct

Essential thrombocythemia terminating in pure erythroleukemia

2004

Transformation into acute leukemia is a rare event in essential thrombocythemia (ET). The blasts are usually of myeloid, rarely of megakaryoblastic differentiation. We present the case of a patient with pure erythroleukemia after a nearly 10-year course of ET, which was treated with hydroxyurea. The patient, a 58-year-old male, presented with an elevated thrombocyte count (926,000/μL) and normal values of hemoglobin and leukocytes. After 10 years of therapy with hydroxyurea, the patient developed acute leukemia of solely erythroid differentiation. Chemotherapy with cytarabine and daunorubicin resulted in incomplete remission. The patient died 2 months after diagnosis of acute erythroleukemi…

Malemedicine.medical_specialtyTime FactorsMyeloidDaunorubicinmedicine.medical_treatmentFatal OutcomeBone Marrowhemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansThrombocytosisChemotherapyAcute leukemiaHematologybusiness.industryEssential thrombocythemiaHematologyMiddle Agedmedicine.diseaseCell Transformation Neoplasticmedicine.anatomical_structureImmunologyCytarabineAcute erythroleukemiaLeukemia Erythroblastic Acutebusinessmedicine.drugAmerican Journal of Hematology
researchProduct

Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction.

2007

Neutrophil to lymphocyte ratio (N/L) has been associated with poor outcomes in patients who underwent cardiac angiography. Nevertheless, its role for risk stratification in acute coronary syndromes, specifically in patients with ST-segment elevation myocardial infarction (STEMI), has not been elucidated. We sought to determine the association of N/L maximum value (N/L max) with mortality in the setting of STEMI and to compare its predictive ability with total white blood cell maximum count (WBC max). We analyzed 515 consecutive patients admitted with STEMI to a single university center. White blood cells (WBC) and differential count were measured at admission and daily for the first 96 hour…

Malemedicine.medical_specialtyTime FactorsNeutrophilsMyocardial InfarctionCoronary AngiographyElectrocardiographyLeukocyte CountWhite blood cellInternal medicineCause of DeathConfidence IntervalsST segmentMedicineHumansMyocardial infarctionLymphocytesNeutrophil to lymphocyte ratioAgedProportional Hazards ModelsRetrospective Studiesmedicine.diagnostic_testbusiness.industryProportional hazards modelST elevationMiddle Agedmedicine.diseasePrognosisSurvival Ratemedicine.anatomical_structureCardiologyFemaleMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesThe American journal of cardiology
researchProduct

Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial.

1980

Summary— Forty-two patients with previously untreated T3/4 N1-4 MO/1 prostatic adenocarcinoma were treated with either cyproterone acetate (n=21; 300 mg intramuscularly per week) or oestradiol undecylate (n=21; 100 mg intramuscularly per month) after extensive staging which included open skeletal biopsy and pelvic lymphadenectomy in some cases. Subjective and objective parameters as well as signs of drug toxicity were recorded regularly. Evaluation after 6 months showed cyproterone acetate to be more effective in the following respects: (1) the significantly different castration effect as judged by plasma testosterone, (2) the objective voiding pattern and tumour response, with regression o…

Malemedicine.medical_specialtyTime FactorsUrologyUrologyAdenocarcinomachemistry.chemical_compoundRandom AllocationBiopsymedicineHumansCyproteronePelvic lymphadenectomyDrug toxicityTestosteroneAgedClinical Trials as Topicmedicine.diagnostic_testEstradiolProstatic adenocarcinomabusiness.industryCyproterone acetateCancerProstatic NeoplasmsMiddle Agedmedicine.diseaseSurgeryCastrationchemistrybusinessBritish journal of urology
researchProduct

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent…

2015

Summary Background Acute myeloid leukaemia mainly affects elderly people, with a median age at diagnosis of around 70 years. Although about 50–60% of patients enter first complete remission upon intensive induction chemotherapy, relapse remains high and overall outcomes are disappointing. Therefore, effective post-remission therapy is urgently needed. Although often no post-remission therapy is given to elderly patients, it might include chemotherapy or allogeneic haemopoietic stem cell transplantation (HSCT) following reduced-intensity conditioning. We aimed to assess the comparative value of allogeneic HSCT with other approaches, including no post-remission therapy, in patients with acute…

Malemedicine.medical_specialtyTransplantation ConditioningGemtuzumab ozogamicinmedicine.medical_treatmentAntibodies Monoclonal HumanizedCOUNCIL AML11 TRIALEUROPEAN LEUKEMIANETInternal medicinehemic and lymphatic diseasesAntineoplastic Combined Chemotherapy ProtocolsmedicineClinical endpointINDUCTION CHEMOTHERAPYHumansTransplantation HomologousProspective StudiesADULT PATIENTS610 Medicine & healthBusulfanMETAANALYSISAgedMYELODYSPLASTIC SYNDROMEChemotherapyRISK-ADAPTED APPROACHbusiness.industryRemission InductionHematopoietic Stem Cell TransplantationInduction chemotherapyHematology1ST COMPLETE REMISSIONTotal body irradiationMiddle AgedGemtuzumabGEMTUZUMAB OZOGAMICINSurgeryFludarabineTransplantationSurvival RateLeukemia Myeloid AcuteAminoglycosidesTreatment OutcomeSURVIVALFemaleNeoplasm Recurrence LocalbusinessBusulfanVidarabinemedicine.drugLancet. Haematology
researchProduct